- Home
- INM vs LEO Comparison
INM vs LEO Comparison
Compare INM & LEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- LEO
- Stock Information
- Founded
- INM 1981
- LEO 1987
- Country
- INM Canada
- LEO United States
- Employees
- INM N/A
- LEO N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- LEO Trusts Except Educational Religious and Charitable
- Sector
- INM Health Care
- LEO Finance
- Exchange
- INM Nasdaq
- LEO Nasdaq
- Market Cap
- INM 3.2M
- LEO 363.8M
- IPO Year
- INM N/A
- LEO N/A
- Fundamental
- Price
- INM $2.66
- LEO $5.77
- Analyst Decision
- INM
- LEO
- Analyst Count
- INM 0
- LEO 0
- Target Price
- INM N/A
- LEO N/A
- AVG Volume (30 Days)
- INM 5.8M
- LEO 200.2K
- Earning Date
- INM 05-12-2025
- LEO 01-01-0001
- Dividend Yield
- INM N/A
- LEO 4.01%
- EPS Growth
- INM N/A
- LEO N/A
- EPS
- INM N/A
- LEO 0.04
- Revenue
- INM $4,920,990.00
- LEO N/A
- Revenue This Year
- INM N/A
- LEO N/A
- Revenue Next Year
- INM N/A
- LEO N/A
- P/E Ratio
- INM N/A
- LEO $152.00
- Revenue Growth
- INM N/A
- LEO N/A
- 52 Week Low
- INM $1.72
- LEO $4.98
- 52 Week High
- INM $15.70
- LEO $6.50
- Technical
- Relative Strength Index (RSI)
- INM 45.77
- LEO 38.19
- Support Level
- INM $2.69
- LEO $5.90
- Resistance Level
- INM $3.28
- LEO $5.86
- Average True Range (ATR)
- INM 0.20
- LEO 0.06
- MACD
- INM -0.05
- LEO -0.02
- Stochastic Oscillator
- INM 9.81
- LEO 8.00
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
About LEO BNY Mellon Strategic Municipals Inc.
BNY Mellon Strategic Municipals, Inc. is a diversified closed-end management investment company. The fund's investment objective is to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital. Its products are Equity and Fixed Income Mutual Funds, Retail Money Market Funds, Government/Treasury Money Market Funds, Institutional Money Market Funds, and others. BNY Mellon and its affiliates, including BNYM Investment Adviser, INA and others involved in the management, sales, investment activities, business operations or distribution of the Fund, are engaged in businesses and have interests other than that of managing the Fund.